Pfizer and 4 Healthcare Stocks Down in an Up Market: PFE, LUX, PPDI, TECH, PKI

Through most of the trading day on Friday, September 16, 2011, these stocks are bringing down the Healthcare (NYSE:XLV) sector. Long time Wall St. Cheat Sheet readers know to watch stock prices because Technicals on the Stock Chart are Strong’ is one of the ‘T’s in our CHEAT SHEET investing framework.

Pfizer Inc. (NYSE:PFE) stocks are trading at $18.32. This is 17 cents (-0.97%) below the previous close of $18.49, making the company one of the biggest price losers in the sector today. Pfizer Inc. is a global pharmaceutical company which develops and manufactures prescription medications for humans and animals.

Stock Price Performance: From June 21, 2011, to September 15, 2011, the stock price had fallen $1.71 (-8.5%) from $20.20 to $18.49. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 2, 2011 when shares rose for seven straight trading days, rising 6.2% (+$1.21). It saw one of its worst periods between July 6, 2011 and July 18, 2011 when shares fell for nine straight trading days, falling 5.5% (-$1.13).

Luxottica Group S.p.A. (NYSE:LUX) is among the price losers in the sector as its stock price is $27.93, down 3 cents (-0.1%) from the previous close of $27.96. Luxottica Group S.p.A designs, manufactures and distributes fashion, luxury and sport/performance eyewear. It operates in two industry segments: manufacturing and wholesale distribution; and retail distribution.

Stock Price Performance: From July 19, 2011, to September 14, 2011, the stock price had fallen $4.75 (-14.9%) from $31.83 to $27.08. The stock price saw one of its best stretches over the last year between March 25, 2011 and April 6, 2011 when shares rose for nine straight trading days, rising 4.7% (+$1.46). It saw one of its worst periods between March 9, 2011 and March 16, 2011 when shares fell for six straight trading days, falling 9.5% (-$3.02).

Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) is among the price losers in the sector. Its shares are trading at $28.77, which is 52 cents (-1.7%) below the previous close of $29.26. Pharmaceutical Product Development, Inc. is a global contract research organization, which provides drug discovery and development services, post-approval expertise and compound partnering programs.

Stock Price Performance: From June 21, 2011, to September 15, 2011, the stock price had risen $3.40 (13.1%) from $25.86 to $29.26. The stock price saw one of its best stretches over the last year between December 7, 2010 and December 16, 2010 when shares rose for eight straight trading days, rising 7.4% (+$1.84). It saw one of its worst periods between March 9, 2011 and March 18, 2011 when shares fell for eight straight trading days, falling 5.5% (-$1.57).

Techne Corporation (NASDAQ:TECH) is among the price losers in the sector as its stock price is $72.55, down 43 cents (-0.6%) from the previous close of $72.96. Techne Corporation and subsidiaries are engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls.

Stock Price Performance: From July 20, 2011, to September 15, 2011, the stock price had fallen $7.82 (-9.7%) from $80.78 to $72.96. The stock price saw one of its best stretches over the last year between April 18, 2011 and April 29, 2011 when shares rose for nine straight trading days, rising 5.9% (+$4.30). It saw one of its worst periods between July 19, 2011 and August 1, 2011 when shares fell for 10 straight trading days, falling 10.8% (-$8.80).

PerkinElmer, Inc. (NYSE:PKI) is one of the sector losers in price. Its shares are trading at $21.04, down 6 cents (-0.2%) from the previous close of $21.08. PerkinElmer, Inc. provides technology, services and solutions to the environmental monitoring, diagnostics, academic research and safety security markets.

Stock Price Performance: From June 21, 2011, to September 15, 2011, the stock price had fallen $5.38 (-20.3%) from $26.46 to $21.08. It saw one of its worst periods between August 15, 2011 and August 22, 2011 when shares fell for six straight trading days, falling 8.6% (-$1.95). The stock price saw one of its best stretches over the last year between December 6, 2010 and December 14, 2010 when shares rose for seven straight trading days, rising 5.2% (+$1.25).